Teva

20 stories about Teva
מוסף 16.5 הון אנושי סול ג'יי בארר  Sol J. Barer

Three Board Members to Leave Distraught Drugmaker Teva

26.04.18|Lilach Baumer and Dror Reich
Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years
מטה טבע פתח תקווה

Teva Blocked From Launching Generic Version of Israeli Sleep Medicine Circadin

17.04.18|Zohar Shahar Levy and Dror Reich
An Israeli court issued a temporary injunction against Teva, following a lawsuit by the brand drug's maker Neurim Pharmaceuticals
אדם נוימן מעצב חללים ל עבודה ב ניו יורק

CTech’s Tuesday Roundup of Israeli Tech News

10.04.18|CTech
Palo Alto Networks to acquire cybersecurity startup Secdo. WeWork scuttles plans to raise funds in Israel. Medtronic acquires medical visualization company Visionsense for $65 million
מפעל טבע נתניה

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich
Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners
הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
אלביט מערכות נתנאל גרופ פארק תמר רחובות

CTech’s Thursday Israeli Tech News Roundup

15.03.18|CTech
Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees
יו"ר ועד עובדי טבע כפר סבא אלירן קוזליק

In Protest of New Bonus Plan, Teva Sued by Israeli Employees

15.03.18|Dror Reich
After announcing the cancellation of its annual bonuses for 2017 due to debt, the Israel-based drugmaker rolled out a performance-based bonus scheme for 2018 in February
משרדים טאבולה 1

CTech’s Thursday Israeli Tech News Roundup

08.03.18|CTech
On heels of Facebook feed change, Taboola sketches aggressive expansion. Will and Jaden Smith’s bottled water company Just Goods reboots after burning through $20 million
מנכ"ל טבע החדש קור שולץ 2

Teva Increases Junk Senior Note Offering to $4.5 Billion

08.03.18|Lilach Baumer
Last week the debt-laden drugmaker announced a $3.5 billion-equivalent offering to repay its short-term $1.5 billion outstanding debt due July
איי מרשל

CTech’s Weekly Israeli Tech News Roundup

02.03.18|CTech
Marshall Islands to issue national cryptocurrency. Didi Chuxing to scout Israel for investments, partnerships
מפעל תרופות טבע

CTech’s Daily Israeli Tech News Roundup

01.03.18|CTech
Teva to repay due loans with junk bond private offering. Convicted Comverse CEO Kobi Alexander transferred to Israeli authorities
תרופות  טבע גלולות תרופה

Teva to Repay Due Loans with Junk Bond Private Offering

01.03.18|Lilach Baumer
The debt-laden generic drugmaker is offering around $3.5 billion in senior notes in both dollar and euro denominations
default image

CTech’s Weekly Israeli Tech News Roundup

23.02.18|CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Latest venture by Mobileye founders valued at $1 billion. Intel leads $50 million investment in public transit app Moovit.
מנכ"ל טבע החדש קור שולץ 2

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich
In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need
אינטל קריית גת

CTech’s Daily Israeli Tech News Roundup

21.02.18|CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Intel leads $50 million investment in public transit app Moovit
אורי טל טנא פרשן שוק ההון

Teva No Longer Provides Timeline for Recovery

21.02.18|Uri Tal-Tenne
In 2017, the company said it expected moderate growth in operating profits in the U.S. in 2020
מנכ"ל טבע גנריקה סיגורדור סיגי אולפסון

Drugmaker Hikma Appoints Former Teva Executive as CEO

20.02.18|Asaf Shalev
The appointment of Sigurdur Olafsson comes as Hikma has been struggling to bolster the performance of its generic drugs unit
default image

CTech’s Daily Israeli Tech News Roundup

18.02.18|CTech
Teva turns to meritocracy as part of turnaround plan. On way to crypto offering, copyright protection startup makes misleading claims. Israel could be seeing lower corporate tax rate soon
מנכ"ל טבע החדש קור שולץ

Teva Turns to Meritocracy as Part of Turnaround Plan

18.02.18|Dror Reich
A new policy the company is rolling out would see Teva employees compensated according to key performance indicators